The US food and drug administration perspective on cancer biomarker development

被引:140
作者
Gutman, Steven
Kessler, Larry G.
机构
[1] US FDA, Off In Vitro Diagnost Devices, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
[2] US FDA, Off Sci, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
[3] US FDA, Engn Labs, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nrc1911
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?
引用
收藏
页码:565 / 571
页数:8
相关论文
共 37 条
  • [1] New developments in the staging of melanoma
    Baruch, AC
    Shi, JQ
    Feng, YM
    Nelson, MA
    [J]. CANCER INVESTIGATION, 2005, 23 (06) : 561 - 567
  • [2] Translational crossroads for biomarkers
    Bast, RC
    Lilja, H
    Urban, N
    Rimm, DL
    Fritsche, H
    Gray, J
    Veltri, R
    Klee, G
    Allen, A
    Kim, N
    Gutman, S
    Rubin, MA
    Hruszkewycz, A
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6103 - 6108
  • [3] Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
    Bossuyt, PM
    Reitsma, JB
    Bruns, DE
    Gatsonis, CA
    Glasziou, PP
    Irwig, LM
    Lijmer, JG
    Moher, D
    Rennie, D
    de Vet, HCW
    [J]. CLINICAL CHEMISTRY, 2003, 49 (01) : 1 - 6
  • [4] CAMPBELL G, 2004, J BIOPHARM STAT, V14, P529
  • [5] Pancreatic cancer proteome: The proteins that underlie invasion, metastasis, and immunologic escape
    Chen, R
    Yi, EC
    Donohoe, S
    Pan, S
    Eng, J
    Cooke, K
    Crispin, DA
    Lane, ZL
    Goodlett, DR
    Bronner, MP
    Aebersold, R
    Brentnall, TA
    [J]. GASTROENTEROLOGY, 2005, 129 (04) : 1187 - 1197
  • [6] *CLIN LAB STAT I, ASS CLIN ACC LAB TES
  • [7] Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems
    Diamandis, EP
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05): : 353 - 356
  • [8] Sample size determination in microarray experiments for class comparison and prognostic classification
    Dobbin, K
    Simon, R
    [J]. BIOSTATISTICS, 2005, 6 (01) : 27 - 38
  • [9] DORRIS DR, 2002, LANCET, V359, P572
  • [10] Spectrum bias: a quantitative and graphical analysis of the variability of medical diagnostic test performance
    Goehring, C
    Perrier, A
    Morabia, A
    [J]. STATISTICS IN MEDICINE, 2004, 23 (01) : 125 - 135